- Home
- MVIS vs RENB Comparison
MVIS vs RENB Comparison
Compare MVIS & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVIS
- RENB
- Stock Information
- Founded
- MVIS 1993
- RENB 2011
- Country
- MVIS United States
- RENB United States
- Employees
- MVIS N/A
- RENB N/A
- Industry
- MVIS Industrial Machinery/Components
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- MVIS Technology
- RENB Health Care
- Exchange
- MVIS Nasdaq
- RENB Nasdaq
- Market Cap
- MVIS 234.3M
- RENB 279.3M
- IPO Year
- MVIS 1996
- RENB N/A
- Fundamental
- Price
- MVIS $1.03
- RENB $1.89
- Analyst Decision
- MVIS Hold
- RENB
- Analyst Count
- MVIS 2
- RENB 0
- Target Price
- MVIS $3.00
- RENB N/A
- AVG Volume (30 Days)
- MVIS 3.0M
- RENB 993.0K
- Earning Date
- MVIS 11-07-2024
- RENB 02-12-2025
- Dividend Yield
- MVIS N/A
- RENB N/A
- EPS Growth
- MVIS N/A
- RENB N/A
- EPS
- MVIS N/A
- RENB N/A
- Revenue
- MVIS $8,147,000.00
- RENB N/A
- Revenue This Year
- MVIS $24.78
- RENB N/A
- Revenue Next Year
- MVIS $451.78
- RENB N/A
- P/E Ratio
- MVIS N/A
- RENB N/A
- Revenue Growth
- MVIS 277.53
- RENB N/A
- 52 Week Low
- MVIS $0.80
- RENB $0.40
- 52 Week High
- MVIS $2.98
- RENB $5.25
- Technical
- Relative Strength Index (RSI)
- MVIS 51.19
- RENB 71.21
- Support Level
- MVIS $0.82
- RENB $1.50
- Resistance Level
- MVIS $0.85
- RENB $2.00
- Average True Range (ATR)
- MVIS 0.06
- RENB 0.32
- MACD
- MVIS 0.01
- RENB 0.05
- Stochastic Oscillator
- MVIS 66.67
- RENB 88.97
About MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.